Mhd Majed Abdul Wahab, | |
205 S Front St Ste 3c, Harrisburg, PA 17104-1619 | |
(717) 231-8506 | |
Not Available |
Full Name | Mhd Majed Abdul Wahab |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 205 S Front St Ste 3c, Harrisburg, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083237523 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | MT220762 (Pennsylvania) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mhd Majed Abdul Wahab, 101 S 2nd St, Harrisburg, PA 17101-2509 Ph: (216) 309-8762 | Mhd Majed Abdul Wahab, 205 S Front St Ste 3c, Harrisburg, PA 17104-1619 Ph: (717) 231-8506 |
News Archive
Neuroscientists have long believed that vision is processed in the brain along circuits made up of neurons, similar to the way telephone signals are transferred through separate wires from one station to another.
Sprint speed, height, and weight are the best predictors of how high school football players will be ranked by college recruiting scouts, reports a study in the May issue of The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association.
EpiCept Corporation announced today that the Company's common stock has been included on a list of preliminary additions to the Russell Microcap Index posted by Russell Investments on June 11, 2010 on www.russell.com. These changes are expected to go into effect after the close of trading on Friday, June 25, 2010.
Riverview Medical Center Foundation is proud to announce two substantial gifts, totaling $10 million, which will significantly impact the way health care is delivered in our community. First, Joan and Robert Rechnitz, founders of the Two River Theater Company, donated $5 million to Riverview Medical Center Foundation to support the launch of an integrative medicine program.
Techulon Inc., an early stage life sciences company has signed an agreement with Nacalai USA, Inc. and its parent company Nacalai Tesque, Inc. for distribution of its Glycofect Transfection Reagent platform products in Japan. Glycofect is a polymeric transfection reagent designed to be particularly effective in primary cells of therapeutic interest. It is being used by government, university and corporate laboratories around the world for advanced research towards better understanding of cell biology and for development of new cell-based therapeutics.
› Verified 1 days ago